Podcast host Meghan McCain, the former co-host of “The View,” made headlines when she posted to social media recently in ...

A new COVID variant, NB 1.8.1, is being detected across California; here are the symptoms to watch for, and vaccinations you'll need to take.

Healthcare companies are navigating a challenging environment as policy uncertainty and competitive pressures weigh on the ...

US drug companies are increasingly licensing experimental medicines invented by Chinese firms. The recent deals could be ...

BMY teams with BioNTech on BNT327, a dual-target cancer therapy, as legacy drugs face mounting generic pressure ...

Trastuzumab deruxtecan plus pertuzumab outperformed standard-of-care therapy as first-line treatment for HER2-positive ...

The PD-(L)1xVEGF field had a roller coaster week marked by an imperfect readout and a potentially $11 billion deal. | The PD- ...

Bristol-Myers Squibb and BioNTech announced a major deal worth up to $11 billion in early June. Click here to find out why I ...

Princeton: BioNTech SE and Bristol Myers Squibb have announced that the companies have entered into an agreement for the ...

The chief executive of a speciality chemicals giant which is one of only two Yorkshire-headquartered FTSE 100 constituents ...

Bristol Myers and BioNTech are teaming up to develop and commercialize BNT327, a cancer therapy with blockbuster ambition.